In today’s market, distressed companies and assets are plentiful. Learn from experienced M&A veterans how best to take advantage of these situations. How do you buy distressed companies and stay healthy and profitable? What are the inherent risks? How do you manage the unknown liabilities and integration?
Panelists:
-
Jackson Craig, Managing Director, H.I.G. Capital
-
Charles R. Dougherty, Managing Director, BR Strategies, LLC
-
Richard L. Vieira, Co-Founder and Managing Partner, 2SV Capital, LLC
Related Insights
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.
17 February 2025
Foley Viewpoints
6 Steps to Manage Tariff Risks in a Trade War
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import must determine the best strategy to deal with the resulting uncertainties.
25 February 2025
Events
Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks
Join Foley and Lardner LLP partners Greg Husisian, Leah Imbrogno, and Vanessa Miller on Tuesday, February 25, for a Strafford CLE webinar, “Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks.”